chronic%20obstructive%20pulmonary%20disease
CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Chronic obstructive pulmonary disease (COPD) is an inflammatory respiratory disease characterized by reversible airflow limitation.

The patient usually have chronic cough, sputum production or dyspnea with or without history of risk factors for the disease.

The chronic airflow limitation is caused by a combination of small airways disease and parenchymal destruction.

It is a preventable & treatable disease.

  1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995 Nov;152(5)(Pt 2):S77-S121. PMID: 7582322
  2. The Asia Pacific COPD Roundtable Group. Global Initiative for Chronic Obstructive Lung Disease strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: an Asia-Pacific perspective. Respirology. 2005 Jan;10(1):009-17. PMID: 15691232
  3. Ambrosino N, Vagheggini G. Non-invasive ventilation in exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2007 Dec;2(4):471-476. PMID: 18268921
  4. Blanchard AR. Treatment of COPD exacerbations: pharmacologic options and modification of risk factors. Postgrad Med. 2002 Jun;111(6):65-75. PMID: 12082921
  5. Decramer M, Celli B, Kesten S, et al; UPLIFT investigators. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009 Oct;374(9696):1171-1178. PMID: 19716598
  6. Ferguson GT, Calverley PM, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the Towards a Revolution in COPD Health study. Chest. 2009 Dec;136(6):1456-1465. PMID: 19581353
  7. National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care [full version of NICE guideline No.12]. Thorax. 2004 Feb;59(Suppl 1):001-232. PMID: 15041752
  8. Doherty DE. Early detection and management of COPD: what you can do to reduce the impact of this disabling disease. Postgrad Med. 2002 Jun;111(6):41-4, 49-50, 53 passim. PMID: 12082920
  9. Gross N, Levin D. Primary care of the patient with chronic obstructive pulmonary disease-part 2: pharmacologic treatment across all stages of disease. Am J Med. 2008 Jul;121(7)(Suppl):S13-S24. PMID: 18558103
  10. O'Donnell DE, Aaron S, Bourbeau J, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. Can Respir J. 2007 Sep;14(Suppl B):5B-32B. PMID: 17885691
  11. O'Donnell DE, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J. 2008 Jan;15(Suppl A):1A-8A. PMID: 18292855
  12. Tashkin DP, Celli B, Senn S, et al for the UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008 Oct;359(15):1543-1554. PMID: 18836213
  13. Qaseem A, Snow V, Shekelle P, et al; Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007 Nov;147(9):633-638. PMID: 17975186
  14. Rennard SI. Overview of causes of COPD. New understanding of pathogenesis and mechanisms can guide future therapy. Postgrad Med. 2002 Jun;111(6):28-38. PMID: 12082919
  15. Snow V, Lascher S, Mottur-Pilson C; Joint Expert Panel on Chronic Obstructive Pulmonary Disease of the American College of Chest Physicians and the American College of Physicians-American Society of Internal Medicine. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2001 Apr;134(7):595-599. PMID: 11281744
  16. Yassin HM, Dever LL. Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections. Expert Opin Investig Drugs. 2001 Feb;10(2):353-367. PMID: 11178347
  17. MedWormhttp://www.medworm.com/rss/index.php/Respiratory-Medicine/40/http://www.medworm.com/rss/medicalfeeds/specialities/Respiratory-Medicine.xml
  18. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. http://guidance.nice.org.uk/. 2010.
  19. Global Initiative for Chronic Obstructive Lung Disease. At-A-Glance outpatient management reference for chronic obstructive disease (COPD). Based on the global strategy for diagnosis, management and prevention of COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD) revised 2011. http://www.goldcopd.org/. Jan 2012.
  20. Ministry of Health Singapore. Clinical practice guidelines: chronic obstructive pulmonary disease. MOH (Singapore). http://www.moh.gov.sg. 2006
  21. National Heart, Lung and Blood institute. Global Initiative for Asthma. Global strategy for asthma management and prevention. http://www.ginasthma.org/. 2006. Accessed 07 Sep 2007.
  22. National Heart, Lung, and Blood Institute. Global Initiative for Asthma. Global strategy for asthma management and prevention Updated 2009. 2009
  23. National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. NICE. http://www.nice.org.uk. 2004.
  24. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.org/. 2011.
  25. Alberta Medical Association. Guideline for the management of acute exacerbations of chronic bronchitis (AECB)/acute or chronic COPD. Alberta Medical Association. http://www.albertadoctors.org/. May 2000. Accessed 05 Aug 2002.
  26. Institute for Clinical Systems Improvement (ICSI). Health care guideline: chronic obstructive pulmonary disease. http://www.icsi.org. 2004
  27. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2014. Global Initiative for Chronic Obstructive Lung Disease website. http://www.goldcopd.org/. 2014. Accessed 15 Apr 2015.
  28. Global Initiative for Chronic Obstructive Lung Disease. Pocket guide to COPD diagnosis, management, and prevention. A guide for health care professionals. Updated 2014. http://www.goldcopd.org/. 2014. Accessed 15 Apr 2015.
  29. Qaseem A, Wilt TJ, Weinberger SE et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011 Aug;155(3):179-191. doi: 10.7326/0003-4819-155-3-201108020-00008. PMID: 21810710
  30. American Thoracic Society. COPD assessment test (CAT). American Thoracic Society website. http://www.thoracic.org/. 2014.
  31. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2015. GOLD website. http://www.goldcopd.org/. 2015. Accessed 30 Apr 2015.
  32. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2017 report. Global Initiative for Chronic Obstructive Lung Disease (GOLD). http://goldcopd.org/. 2017.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 08 Jun 2016
Middle East Respiratory Syndrome (MERS) patients have more severe illness and a higher mortality rate than non-MERS severe acute respiratory infection (SARI) patients, according to a study presented at the recent American Thoracic Society (ATS) International Conference 2016 held in San Francisco, California, US.
Rachel Soon, 04 Aug 2017

Investment in health crisis response systems during non-pandemic periods is crucial to combating the next inevitable flu pandemic, according to a government representative.

30 Apr 2016
New drug applications approved by US FDA as of 16 - 30 Apr 2016 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
15 Jan 2017
New drug applications approved by US FDA as of 1 - 15 January 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.